Vitamin D in clinical decision-making
Vitamin D testing has become one of the most commonly ordered laboratory tests worldwide, and for good reason. The clinical implications of vitamin D deficiency extend far beyond the classical bone metabolism pathway. Emerging evidence links suboptimal 25(OH)D levels to immune dysregulation, increased infection susceptibility, cardiovascular risk, autoimmune disease progression, and adverse pregnancy outcomes. For clinicians, the challenge lies not in ordering the test but in interpreting results within the appropriate clinical context.
Choosing the right threshold
There is ongoing debate about optimal vitamin D levels. The Endocrine Society considers levels below 20 ng/mL (50 nmol/L) deficient and below 30 ng/mL (75 nmol/L) insufficient. However, some researchers and functional medicine practitioners advocate for target ranges of 40–60 ng/mL for immune optimisation and disease prevention. The important clinical principle is that thresholds should be informed by the patient's clinical context — a postmenopausal woman with osteopenia has different targets than an otherwise healthy 30-year-old.
Monitoring supplementation response
One of the most valuable clinical applications of vitamin D testing is monitoring response to supplementation. Dose-response varies widely between individuals due to differences in body weight (vitamin D is sequestered in adipose tissue), genetic polymorphisms affecting vitamin D metabolism (VDR, CYP2R1, CYP24A1 variants), absorption capacity, and baseline level. A standard 1000 IU daily dose may raise levels by 10 ng/mL in a lean individual but only 3–4 ng/mL in someone with obesity. Testing removes the guesswork and enables personalised dosing.
Special clinical populations
Certain patient populations warrant routine vitamin D monitoring: chronic kidney disease patients (impaired 1-alpha-hydroxylation), those on anticonvulsants or glucocorticoids (accelerated vitamin D catabolism), bariatric surgery patients (malabsorption), individuals with inflammatory bowel disease, and patients with granulomatous diseases where unregulated 1,25(OH)2D production can cause hypercalcaemia. In these groups, testing is not optional — it is essential for safe, effective management.
Frequently asked questions
How quickly does vitamin D level change after starting supplements?
Serum 25(OH)D levels typically begin to rise within 1–2 weeks of supplementation, but steady-state levels are not achieved for 6–8 weeks. Retesting is most informative after 8–12 weeks on a consistent dose.
Can vitamin D levels be too high?
Yes. Vitamin D toxicity (levels above 100 ng/mL or 250 nmol/L) can cause hypercalcaemia, kidney damage, and soft tissue calcification. This is almost always the result of excessive supplementation, not dietary intake or sun exposure. Periodic testing prevents oversupplementation.
Explore This Test
View method details, sample requirements, and analyte panel for our Vitamin D test.
View Vitamin D →